REFERENCES
- Shoulson I., Glaubiger G. A., Chase T. N. Neurology 1975; 25: 1144–1148
- Quinn N. P. Drugs 1984; 28: 236–262
- Sudo J., Iwase H., Terui J., Kakuno K., Soyama M, Takayama K., Nagai T. Eur. J. Pharm. Sci. 1998; 7: 67–71
- Sudo J., Iwase H., Terui J., Hayashi T., Soyama M. Biol. Pharm. Bull. 1995; 18: 610–614
- Eriksson B.-M, Persson B.-A. J. Chromatogr. 1982; 228: 143–154
- Okamoto H., Hashida M., Sezaki H. J. Pharm. Sci. 1988; 774: 418–424
- Ohara N., Takayama K., Machida Y., Nagai T. Int. J. Pharm. 1994; 105: 31–38
- Murata M., Mizusawa H., Yamanouchi H., Kanazawa I. J. Neural. Transm. 1996; 103: 1177–1185
- Rahman M. K., Nagatsu T., Kato T. Biochem. Pharmacol. 1981; 30: 645–649
- Sperk G., Galhaup I., Schlögl E., Hörtnagl H., Hornykiewicz O. J. Neurochem. 1980; 35: 972–976
- Borchardt R. T., Vince W. C., Grunewald G. L. Anal. Biochem. 1977; 82: 149–157
- Ellenhorn M. J., Barceloux D. G. Medical Toxicology. Diagnosis and Treatment of Human Poisoning. Elsevier, New York 1988; 16–17
- Reimherr F. W., Wood D. R., Wender P. H. Am. J. Psychiatry 1980; 137: 73–75